Nation-wide survey of advanced non-melanoma skin cancers treated at dermatology departments in Japan
- 1 December 2018
- journal article
- research article
- Published by Elsevier in Journal of Dermatological Science
- Vol. 92 (3) , 230-236
Abstract
No abstract availableKeywords
Funding Information
- AMED (JP18lk0201063)
- Japan Skin Cancer Society
This publication has 35 references indexed in Scilit:
- Human epidermal growth factor receptor 2 protein overexpression and gene amplification in extramammary Paget diseaseBritish Journal of Dermatology, 2013
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerNew England Journal of Medicine, 2012
- Treatment outcomes in a large cohort of patients with invasive Extramammary Paget's diseaseGynecologic Oncology, 2012
- Sorafenib for Patients with Advanced Angiosarcoma: A Phase II Trial from the French Sarcoma Group (GSF/GETO)The Oncologist, 2012
- Inhibition of Mutated, Activated BRAF in Metastatic MelanomaNew England Journal of Medicine, 2010
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- HER-2/neu targeting for recurrent vulvar Paget's diseaseGynecologic Oncology, 2008
- Cutaneous soft tissue sarcoma incidence patterns in the U.S.Cancer, 2008
- Docetaxel: A therapeutic option in the treatment of cutaneous angiosarcomaCancer, 2007
- Metastatic extramammary Paget's disease successfully controlled with tumour dormancy therapy using docetaxelBritish Journal of Dermatology, 2005